| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.45 |
8e-35 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.47 |
1e-24 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
2e-21 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
4e-14 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-13 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.38 |
5e-13 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
3e-12 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.33 |
5e-12 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-11 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-11 |